Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Farmaceutica RemediaLTS:0M8I 58 Interest Coverage is 94.75 as of Mar. 2026, which is 53% above its 10-year median of 61.75. GuruFocus rates LTS:0M8I with a GF Score™ of 58/100 and a GF Value™ of lei0.23. The stock has 8 warning signs investors should review. Among 89 Medical Distribution companies, Farmaceutica Remedia ranks better than 87.64% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Farmaceutica Remedia's
Operating Income
for the
three
months ended in Mar. 2026 was lei1.1 Mil. Farmaceutica Remedia's Interest Expense for the
three
months ended in Mar. 2026 was lei-0.0 Mil.
Farmaceutica Remedia's interest coverage for the quarter that ended in Mar. 2026 was 94.75.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Farmaceutica Remedia SA has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Farmaceutica Remedia's Interest Coverage or its related term are showing as below:
LTS:0M8I'
s Interest Coverage Range Over the Past 10 Years
Min: 25.85 Med: 61.75 Max: 311.1
Current: 253.74
LTS:0M8I's Interest Coverage is ranked better than 87.64% of 89
companies
in the Medical Distribution industry
Industry Median: 6.23
vs LTS:0M8I: 253.74
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Farmaceutica Remedia Interest Coverage Related Terms
Farmaceutica Remedia Interest Coverage Historical Data
* Premium members only.
The historical data trend for Farmaceutica Remedia's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
LTS:0M8I vs MCK, CAH, COR: Interest Coverage Comparison
For the Medical Distribution subindustry, Farmaceutica Remedia's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Farmaceutica Remedia Interest Coverage vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Farmaceutica Remedia's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Farmaceutica Remedia's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Farmaceutica Remedia (LTS:0M8I) has a Interest Coverage of 94.75 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Farmaceutica Remedia and its competitors. This is 53% above median its historical median of 61.75. Over the past decade, Farmaceutica Remedia's Interest Coverage has ranged from 25.85 to 311.10. According to the industry distribution chart, Farmaceutica Remedia ranks #11 out of 89 companies in the Medical Distribution industry, placing it in the top 12.4%.
Is Farmaceutica Remedia's Interest Coverage too high?
Farmaceutica Remedia's current Interest Coverage of 94.75 is 53% above median its 10-year median of 61.75. Over the past 10 years, this metric has ranged from a low of 25.85 to a high of 311.10. The Medical Distribution industry median Interest Coverage is 6.23. Farmaceutica Remedia's value of 94.75 is 1420.9% above this industry median. Based on the distribution chart, Farmaceutica Remedia ranks #11 out of 89 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Farmaceutica Remedia has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Farmaceutica Remedia's Interest Coverage compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Farmaceutica Remedia ranks #11 out of 89 companies for Interest Coverage. This places Farmaceutica Remedia in the top 12% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 6.23. Farmaceutica Remedia's value of 94.75 is 1420.9% above this benchmark. Historically, Farmaceutica Remedia's own Interest Coverage has ranged from 25.85 to 311.10 over the past decade. While the company's 10-year median is 61.75 vs. the industry median of 6.23, Farmaceutica Remedia has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Distribution company?
The median Interest Coverage among Medical Distribution companies is 6.23, based on 89 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Farmaceutica Remedia's current Interest Coverage of 94.75 is 1420.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Farmaceutica Remedia and its competitors. For the Medical Distribution industry, the median Interest Coverage is 6.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farmaceutica Remedia's current Interest Coverage is 94.75, which is 53% above median its own 10-year median of 61.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farmaceutica Remedia stock overvalued right now?
Farmaceutica Remedia (LTS:0M8I) has a current Interest Coverage of 94.75. The stock's GF Value™ is lei0.23, compared to a current price of lei0.25 — trading 8.7% above its estimated fair value. The current Interest Coverage is 94.75, which is 53% above median its 10-year median of 61.75 and 1420.9% above the Medical Distribution industry median of 6.23. Farmaceutica Remedia's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Farmaceutica Remedia (LTS:0M8I), the current Interest Coverage is 94.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Farmaceutica Remedia (LTS:0M8I) Overvalued in 2026?
Based on GuruFocus' analysis, Farmaceutica Remedia stock appears to be overvalued.
The current stock price of lei0.25 is trading 8.7% above its estimated GF Value™ of lei0.23.
Key valuation signals for LTS:0M8I:
Interest Coverage: 94.75 (53% above median its 10-year median of 61.75)
GF Value™: lei0.23 vs. price of lei0.25 (8.7% above fair value)
Industry Position: 1420.9% above the Medical Distribution median (#11 of 89)
No single metric tells the full story. See the LTS:0M8I stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.
58GF Score
Get the complete analysis for LTS:0M8I
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0M8I has been successfully added to your 
